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Several important contributions in the ﬁ  eld of metabolic 
alterations of critical illness were published in Critical 
Care in 2009. Th  ese articles can be gathered into three 
areas of interest: the physiology and clinical management 
of glucose control; enteral nutrition and gastrointestinal 
disorders; and critical-illness-related endocrine and 
neuro muscular  alterations.
Glucose metabolism and control
Since 2001 and the publication of the ‘Leuven I’ study [1], 
the metabolism and control of blood glucose is an area of 
intense research in intensive care medicine. Th  e con-
trasting ﬁ  ndings of subsequent prospective randomized 
controlled trials of glucose control fostered research in 
several diﬀ  erent  ﬁ   elds: epidemiological insights came 
from association studies between blood glucose and 
outcome; endocrinological pathways were investigated as 
potential contributors to stress hyperglycaemia; and 
computer-assisted decision systems and continuous 
glucose monitoring were assessed in clinical conditions.
Association between blood glucose levels and outcome
An association between high admission blood glucose 
concentration and worse vital outcome has been known of 
for several decades. Interestingly, an analysis of a database 
of more than 250,000 patients allowed further 
categorisation of the type of patients in which the 
relationship between blood glucose and mortality was the 
strongest after acute myocardial infarction, arrhythmia, 
unstable angina or pulmonary embolism [2]. Likewise, the 
presence of hypoglycaemia at the time of admission or 
during critical illness is also associated with increased 
mortality, as reviewed recently [3]. An important article 
published in 2009 in Critical Care summarises the analysis 
of a 5-year database from the Australia New Zealand 
Intensive Care Society including 66,184 adult admissions 
[4]. Th  ese authors indeed reported that the presence of 
early hypoglycaemia is common and associated with lower 
survival rates, especially in some subsets of patients. High 
early blood glucose variability (that is, during the ﬁ  rst 24 
hours of ICU stay) was also associated with higher 
adjusted ICU and hospital mortality.
Physiopathology of stress hyperglycaemia
New important insights into the physiopathology of 
stress hyperglycaemia were also reported in Critical Care
last year. In particular, the underlying mechanisms of 
insulin resistance were investigated by Langouche and 
colleagues [5] in a set of 318 critically ill patients. Th  ese 
authors recorded the circulating blood levels of 
adiponectin, retinol binding protein 4 and leptin, three 
adipokines known to be involved in the modulation of 
insulin sensitivity and action. Th  e levels of all three 
adipokines were lower than in normal subjects and 
intensive insulin therapy inﬂ  uenced the concentrations of 
adiponectin and retinol binding protein  4. Similarly, 
Venkatesh and colleagues reported in Critical Care [6] 
decreases in the mean plasma adiponectin concentration 
of 23 critically ill patients compared to historical control 
subjects. Interestingly, a correlation was found between 
adiponectin and plasma cortisol levels, and an inverse 
correlation was found between adiponectin and C-
reactive protein levels. Circulating levels of resistin, 
another recently reported hormone released by adipo-
cytes and macrophages, were found to be increased in a 
population of 170 critically ill patients [7]; a correlation 
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reported. Th  ese important ﬁ  ndings are quite consistent 
with recent progress in understanding the changes in 
adipose tissue gene expression during critical illness [8,9].
Another potentially important pathophysiological 
insight was reported by Preissig and colleagues in Critical 
Care in 2009 [10]. Th  e pancreatic endocrine function of 
critically ill children admitted to a paediatric ICU with 
respiratory or cardiovascular failure was studied by the 
simultaneous analysis of blood glucose and plasmatic 
C-peptide levels. A severe primary beta-cell dysfunction 
reﬂ  ected by inappropriately low levels of C-peptide was 
found in children with both respiratory and cardio  vascular 
failure; in contrast, high insulin resistance appeared as the 
prominent cause of stress hyperglycaemia in cases of 
respiratory failure only. Th   ese intriguing ﬁ  ndings of diﬀ  er-
ent and apparently unrelated patho  genetic mecha  nisms of 
stress hyperglycaemia prompted several diﬀ  erent interpre-
tations of the adequacy of the beta-cell response [11,12].
In any case, impairments of glucose metabolism could 
diﬀ   er between children and adults. Th  e important 
paediatric Leuven study published in 2009 by Vlasselaers 
and colleagues [13] conﬁ  rmed some beneﬁ  t of insulin 
therapy dosed to reach ‘age-adjusted normoglycaemia’.
Clinical management of glucose control
Th   e failure to reproduce the results of the Leuven I study 
[1] in diﬀ  erent settings, including two large-scale pros-
pective randomised international trials published in 2009 
[14,15], raised a number of important issues directly 
relevant to daily practice [16].
Th   e two most recent meta-analyses [17,18] were unable 
to demonstrate an advantage of tight glucose control by 
intensive insulin therapy compared to a more conser-
vative approach. As a consequence, the guidelines for 
glucose control were re-assessed in 2009 [19,20] and now 
recommend that blood glucose be kept below 180 mg/dl 
(10.0 mmol/L).
Whatever therapeutic target is chosen, quality of per-
formance is a key factor needed to interpret the outcome 
variables of studies on tight glucose control [21]. Several 
approaches are currently under investiga  tion, not only to 
improve the quality of glucose control, but also to 
increase safety and to decrease glycaemic variability. Th  e 
use of continuous or near-continuous monitor  ing devices 
and closed-loop systems for insulin infusion based on 
systematic algorithms based on multiple-compartment 
models are currently being tested. In Critical Care, Juneja 
and colleagues [22] report their experience of the use of a 
computerized insulin IV protocol program in 4,588 
patients over 21 months. In essence, this study validated 
the eﬃ   cacy of this software as the target glycaemic range 
was rapidly achieved, with a very low rate of hypo-
glycaemia. However, frequent checks of glucose are 
required, implying an adapted nurse to patient ratio. 
Similar ﬁ   ndings were reported by others using other 
computer  ized approaches [23-25]. Th   e use of continuous 
blood glucose monitoring systems is another area of 
intense investigation [26,27].
Enteral nutrition and gastrointestinal disorders
Th   e importance of early enteral nutrition was highlighted 
in 2009 by the publication of a meta-analysis in which a 
signiﬁ  cant reduction in mortality occurred when enteral 
nutrition was instituted within 24 hours after admission 
[28]. However, diﬃ     culties in providing eﬃ   cient  early 
enteral nutrition are frequent and prevent its institution 
in many situations. Clinical studies carried out and 
published in Critical Care in 2009 addressed the issues of 
digestive physiology during critical illness and the inﬂ  u-
ence of enteral nutrition on outcome.
Digestive physiology
Chapman and colleagues [29] published a study concern-
ing the relationship between gastric emptying, glucose 
absorption and glycaemia in critically ill patients. Using a 
3-O-methyl-glucose test, they found that delayed gastric 
emptying decreased glucose absorption in a group of 19 
mechanically ventilated patients compared to 19 healthy 
subjects; conversely, blood glucose concentration aﬀ  ected 
gastric emptying.
Th  e relationship between digestive physiology and 
glucose was further investigated by Deane and colleagues 
[30]. Th  e  eﬀ  ects of exogenous glucagon-like peptide-1 on 
the glycaemic response to small intestinal nutrients was 
studied in critically ill patients. Glucagon-like peptide-1 
is a hormone exerting an ‘incretin’ eﬀ  ect (that is, it stimu-
lates insulin secretion), thereby oﬀ  ering a novel thera-
peutic approach to reduce the magnitude of glycaemic 
responses during enteral feeding.
Enteral nutrition and clinical outcome
Of the unresolved issues regarding enteral nutrition, the 
best site of infusion has still to be determined. White and 
colleagues [31] addressed this question by comparing the 
outcomes of ventilated critically ill patients randomised 
to early post-pyloric or gastric feeding. In essence, early 
post-pyloric feeding did not provide any advantage over 
gastric feeding but did delay the achievement of the 
nutritional target. In terms of outcomes, there were no 
diﬀ  erences between the two groups.
A relationship between the achievement of nutritional 
goals and vital outcome was investigated by Strack van 
Schijndel and colleagues [32] in a prospective obser  va-
tional cohort study of 243 ventilated critically ill patients. 
Th   e caloric and protein targets were analysed separately: 
enteral nutrition was calculated according to indirect 
calori  metry and the protein intake was 1.2 g of protein/kg/
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signiﬁ  cant decreases in ICU and 28 day mortality in the 
female population, while the diﬀ  erence was not signiﬁ  -
cant in males. Th   ese challenging ﬁ  ndings are of interest 
when designing interventional trials. Similarly, another 
observational study reported an association between 
energy and protein intake and vital outcome in subsets of 
obese and lean patients [33].
Th  e addition of pharmaconutrients is another area of 
research. For instance, glutamine could be of particular 
interest in cases of sepsis as it could attenuate inﬂ  am-
mation and increase the heat-shock protein response. 
Th  ese pathways were investigated in healthy volunteers 
receiving endotoxin [34]. Even though endotoxin reduced 
plasma glutamine concentrations, there was no measurable 
eﬀ  ect on cytokine levels, nor on the expression of heat-
shock proteins.
Thyroidal and neuromuscular alterations
Both endocrine and neuromuscular changes are now 
identiﬁ  ed as important contributors to the poor func-
tional outcome of patients with prolonged critical illness. 
For instance, the ‘low T3 syndrome’ has been recognised 
for a long time and its involvement in the need for 
prolonged mechanical ventilation has recently been 
revisited [35], although the pathophysiology of this 
frequent disorder is still incompletely elucidated. Mebis 
and colleagues [36] investigated the expression of genes 
in the hypothalamus of an animal model of chronic critical 
illness and found decreased mRNA levels of thyrotropin 
releasing hormone and increased mRNA levels of type II 
diodinase and thyroid hormone trans  porters.
Th   e neuromuscular consequences encountered in 
patients with prolonged critical illness are responsible for 
several complications [37], including dysfunction of the 
diaphragm muscle [38]. Th  e pathophysiology of ICU-
acquired weakness or critical illness polyneuromyopathy 
is complex and involves increased oxidative stress, 
impaired microcirculation, proteolytic status, cytokine-
related inﬂ  ammation, altered calcium homeostasis, and 
hyperglycaemia [39]. Hermans and colleagues [40] pub-
lished a study in Critical Care that focused on electro-
physiological data from patients in their ICU before and 
after implementation of intensive insuline therapy. In 
their experience, intensive insulin therapy reduced the 
electro  physiological incidence of critical illness poly-
neuro    myopathy and the duration of mechanical venti-
lation. Th  is eﬀ   ect was not found for other thera  peutic 
modalities [41]. Th  e potential mechanisms are partially 
speculative and were discussed in Critical Care [42].
Conclusion
Th  e area of critical-illness-associated metabolic and 
endocrine changes received increased attention in 2009, 
as reﬂ  ected by the articles published. Th   e issues of stress 
hyperglycaemia and glucose control were also further 
investigated. Th  e nutritional aspects of critical illness, 
particularly derangements of the gastrointestinal physio-
logy and the neuromuscular changes found in critically ill 
patients, were re-addressed using new approaches. 
Altogether, new areas of research were opened by the 
high-quality articles published in Critical Care in 2009.
Competing interests
The authors declare that they have no competing interests.
Published: 5 November 2010
References
1.  van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, 
Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy 
in the critically ill patients. N Engl J Med 2001, 345:1359-1367.
2.  Falciglia M, Freyberg RW, Almenoff   PL, D’Alessio DA, Render ML: 
Hyperglycemia-related mortality in critically ill patients varies with 
admission diagnosis. Crit Care Med 2009 , 37:3001-3009.
3.  Lacherade JC Jacqueminet S, Preiser JC: An overview of hypoglycemia in 
the critically ill. J Diabetes Sci Technol 2009, 3:1242-1249.
4.  Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C; ANZICS CORE 
Management Committee: The impact of early hypoglycemia and blood 
glucose variability on outcome in critical illness. Crit Care 2009, 13:R91.
5.  Langouche L, Vander Perre S, Frystyk J, Flyvbjerg A, Hansen TK, Van den 
Berghe G: Adiponectin, retinol-binding protein 4, and leptin in protracted 
critical illness of pulmonary origin. Crit Care 2009, 13:R112.
6.  Venkatesh B, Hickman I, Nisbet J, Cohen J, Prins J: Changes in serum 
adiponectin concentrations in critical illness: a preliminary investigation. 
Crit Care 2009, 13:R105.
7.  Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C: Serum resistin levels in 
critically ill patients are associated with infl  ammation, organ dysfunction 
and metabolism and may predict survival of non-septic patients. Crit Care 
2009, 13:R95.
8.  Jernås M, Olsson B, Sjöholm K, Sjögren A, Rudemo M, Nellgård B, Carlsson LM, 
Sjöström CD: Changes in adipose tissue gene expression and plasma levels 
of adipokines and acute-phase proteins in patients with critical illness. 
Metabolism 2009, 58:102-108.
9. Owecki  M:  Fat tissue and adiponectin: new players in critical care? Crit Care 
2009, 13:174.
10.  Preissig C, Rigby M: Hyperglycaemia results from beta-cell dysfunction in 
critically ill children with respiratory and cardiovascular failure: a 
prospective observational study. Crit Care 2009, 13:R27.
11.  Steil GM, Agus MS: Critical illness hyperglycemia: is failure of the beta-cell 
to meet extreme insulin demand indicative of dysfunction? Crit Care 2009, 
13:129.
12.  Dungan KM, Braithwaite SS, Preiser JC: Stress hyperglycaemia. Lancet 2009, 
373:1798-1807.
13.  Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel 
I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van Cromphaut S, 
Schets M, Van den Berghe G: Intensive insulin therapy for patients in 
paediatric intensive care: a prospective, randomised controlled study. 
Lancet 2009, 373:547-556.
14.  Preiser JC, Devos P, Ruiz-Santana S, Mélot C, Annane D, Groeneveld J, 
Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, 
Stetcher A, Chioléro R: A prospective randomised multi-centre ontrolled 
trial on tight glucose control by intensive insulin therapy in adult 
intensive care units: the Glucontrol study. Intensive Care Med 2009, 
35:1738-1748.
15.  NICE-SUGAR study investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, 
Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, 
Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, 
Potter J, Robinson BG, Ronco JJ: Intensive versus conventional glucose 
control in critically ill patient. N Engl J Med 2009, 360:1283-1297.
16.  Preiser JC, Devos P, Chiolero R: Which factors infl  uence glycemic control in 
the intensive care unit? Curr Opin Clin Nutr Metab Care 2010, 13:205-210.
Huberlant and Preiser Critical Care 2010, 14:238 
http://ccforum.com/content/14/6/238
Page 3 of 417.  Marik PE, Preiser JC: Toward understanding tight glycemic control in the 
ICU: asystematic review and metaanalysis. Chest 2010, 137:544-551.
18.  Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, 
Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D: Intensive insulin 
therapy and mortality among critically ill patients: a meta-anamysis 
including NICE-SUGAR study data. CMAJ 2009, 180:821-827.
19.  Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, 
Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE; American Association 
of Clinical Endocrinologists; American Diabetes Association: American 
Association of Clinical Endocrinologists and American Diabetes 
Association consensus statement on inpatient glycemic control. Diabetes 
Care 2009, 32:1119-1131.
20.  Ichai C, Cariou A, Léone M, Veber B, Barnoud D; le Groupe d’Experts: Expert’s 
formalized recommendations. Glycemic control in ICU and during 
anaesthesia: useful recommendations. Ann Fr Anesth Reanim 2009, 
28:717-718.
21.  Eslami S, Abu-Hanna A, de Keizer NF, Bosman RJ, Spronk PE, de Jonge E, 
Schultz MJ: Implementing glucose control in intensive care: a multicenter 
trial using statistical process control. Intensive Care Med 2010, 36:1556-1565.
22.  Juneja R, Roudebush CP, Nasraway SA, Golas AA, Jacobi J, Carroll J, Nelson D, 
Abad VJ, Flanders SJ: Computerized intensive insulin dosing can mitigate 
hypoglycemia and achieve tight glycemic control when glucose 
measurement is performed frequently and on time. Crit Care 2009, 13:R163.
23.  Cordingley JJ, Vlasselaers D, Dormand NC, Wouters PJ, Squire SD, Chassin LJ, 
Wilinska ME, Morgan CJ, Hovorka R, Van den Berghe G: Intensive insulin 
therapy: enhanced Model Predictive Control algorithm versus standard 
care. Intensive Care Med 2009, 35:123-128.
24.  Le Compte AJ, Lee DS, Chase JG, Lin J, Lynn A, Shaw GM: Blood glucose 
prediction using stochastic modeling in neonatal intensive care. IEEE Trans 
Biomed Eng 2010, 57:509-518.
25.  Pielmeier U, Andreassen S, Juliussen B, Chase JG, Nielsen BS, Haure P: The 
Glucosafe system for tight glycemic control in critical care: a pilot 
evaluation study. J Crit Care 2010, 25:97-104.
26.  Yamashita K, Okabayashi T, Yokoyama T, Yatabe T, Maeda H, Hanazaki K: 
Accuracy and reliability of continuous blood glucose monitor in post-
surgical patient. Acta Anaesthesiol Scand 2009, 53:66-71.
27.  Signal M, Pretty CG, Chase JG, Le Compte A, Shaw GM: Continuous glucose 
monitors and the burden of tight glycemic control in critical care: can they 
cure the time cost? J Diabetes Sci Technol 2010, 4:625-635.
28.  Doig G, Heighes PT, Simpson F, Sweetman EA, Davies AR: Early enteral 
nutrition, provided within 24 hours of injury or intensive care unit 
admission, signifi  cantly reduce mortality in critically ill patients: a meta-
analysis of randomised controlled trials. Intensive Care Med 2009, 
35:2018-2027.
29.  Chapman MJ, Fraser RJ, Matthews G, Russo A, Bellon M, Besanko LK, Jones KL, 
Butler R, Chatterton B, Horowitz M: Glucose absorption and gastric 
emptying in critical illness. Crit Care 2009, 13:R140.
30.  Deane AM, Chapman MJ, Fraser RJ, Burgstad CM, Besanko LK, Horowitz M: 
The eff  ect of exogenous glucagon-like peptide-1 on the glycaemic 
response to small intestinal nutrient in the critically ill: a randomised 
double blind placebo-controlled cross over study. Crit Care 2009, 13:R67.
31.  White H, Sosnowski K, Tran K, Reeves A, Jones M: A randomised controlled 
comparison of early post-pyloric versus early gastric feeding to meet 
nutritional targets in ventilated intensive care patients. Crit Care 2009, 
13:R187.
32.  Strack van Schijndel RJ, Weijs PJ, Koopmans RH, Sauerwein HP, Beishuizen A, 
Girbes AR: Optimal nutrition during the period of mechanical ventilation 
decreases mortality in critically ill, long term acute female patients: a 
prospective observational cohort study. Crit Care 2009, 13:R132.
33.  Alberda C, Gramlich L, Jones N, Jeejeebhoy K, Day AG, Dhaliwal R, Heyland D: 
The relationship between nutritional intake and clinical outcomes in 
critically ill patients: results of an international multicenter observational 
study. Intensive Care Med 2009, 35:1728-1737.
34.  Andreasen AS, Pedersen-Skovsgaard T, Mortensen OH, van Hall G, Moseley 
PL, Pedersen BK: The eff  ect of glutamine nfusion on the infl  ammatory 
response and HSP70 during human experimental endotoxaemia. Crit Care 
2009, 13:R7.
35.  Bello G, Pennisi MA, Montini L, Silva S, Maviglia R, Cavallaro F, Bianchi A, De 
Marinis L, Antonelli M: Nonthyroidal illness syndrome and prolonged 
mechanical ventilation in patients admitted to the ICU. Chest 2009, 
135:1448-1454.
36.  Mebis L, Debaveye Y, Ellger B, Derde S, Ververs EJ, Langouche L, Darras VM, 
Fliers E, Visser TJ, Van den Berghe G: Changes in the central component of 
the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged 
critical illness. Crit Care 2009, 13: R147.
37.  Schweickert WD, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller 
M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall 
JB, Kress JP: Early physical and occupational therapy in mechanically 
ventilated, critically ill patients: a randomised controlled trial. Lancet 2009, 
373:1874-1882.
38.  Sassoon CSh, Caiozzo VJ: Bench-to-bedside review: Diaphragm muscle 
function in disuse and acute high-dose corticosteroid treatment. Crit Care 
2009, 13:221.
39.  Hermans G, Vanhorebeek I, Derde S, Van den Berghe G: Metabolic aspect of 
critical ilness polyneuromyopathy. Crit Care Med 2009, 37:S391-S397.
40.  Hermans G, Schrooten M, Van Damme P, Berends N, Bouckaert B, De Vooght 
W, Robberecht W, Van den Berghe G: Benefi  ts of intensive insulin therapy 
on neuromuscular complications in routine daily critical care practice: a 
retrospective study. Crit Care 2009, 13:R5.
41.  Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G: Interventions for 
preventing critical illness polyneuropathy and critical illness myopathy. 
Cochrane Database Syst Rev 2009, 1:CD006832.
42.  Callahan LA, Supinski GS: Hyperglycemia and acquired weakness in 
critically ill patients: potential mechanisms. Crit Care 2009, 13:125.
doi:10.1186/cc9256
Cite this article as: Huberlant V, Preiser J-C: Year in review 2009: Critical 
care - metabolism. Critical Care 2010, 14:238.
Huberlant and Preiser Critical Care 2010, 14:238 
http://ccforum.com/content/14/6/238
Page 4 of 4